Differential stimulation of VEGF-C production by adhesion/growth-regulatory galectins and plant lectins in human breast cancer cells

Anticancer Research

Volumn 30, Issue 12, 2010, Pages 4829-4834

  Timoshenko, Alexander V ^a   Kaltner, Herbert ^b   André, Sabine ^b   Gabius, Hans Joachim ^b   Lala, Peeyush K ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Agglutinins; Breast cancer cells; Galectins; Glycobiology; Lectins; Lymphangiogenesis; VEGF

Indexed keywords

CONCANAVALIN A; GALECTIN; JACALIN; LECTIN; MESSENGER RNA; VASCULOTROPIN C; WHEAT GERM AGGLUTININ;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL ADHESION; CONCENTRATION RESPONSE; DRUG EFFECT; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPHANGIOGENESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; UPREGULATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CULTURE MEDIA, SERUM-FREE; FEMALE; GALECTINS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PLANT LECTINS; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 78751528213     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Joory KD, Levick JR, Mortimer PS and Bates DO: Vascular endothelial growth factor-C (VEGF-C) expression in normal human tissues. Lymphat Res Biol 4: 73-82, 2006.
2. Timoshenko AV, Chakraborty C, Wagner GF and Lala PK: COX2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer. Br J Cancer 94: 1154-1163, 2006.
3. Szuba A, Skobe M, Karkkainen MJ, Shin WS, Bey net DP, Rockson NB, Dakhil N, Spilman S, Goris ML, Strauss HW, Quertermous T, Alitalo K and Rockson SG: Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J 16: 1985-1987, 2002.
4. Jin DP, An A, Liu J, Nakamura K and Rockson SG: Therapeutic responses to exogenous VEGF-C administration in experimental lymphedema: immunohistochemical and molecular characterization. Lymphat Res Biol 7: 47-57, 2009.
5. Lohela M, Heloterä H, Haiko P, Dumont DJ and Alitalo K: Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues. Am J Pathol 173: 1891-1901, 2008.
6. Pepper MS, Tille JC, Nisato R and Skobe M: Lymphangiogenesis and tumor metastasis. Cell Tissue Res 314: 167-177, 2003.
7. He Y, Karpanen T and Alitalo K: Role of lymphangiogenic factors in tumor metastasis. Biochim Biophys Acta 1654: 3-12, 2004.
8. Chilov D, Kukk E, Taira S, Jeltsch M, Kaukonen J, Palotie A, Joukov V and Alitalo K: Genomic organization of human and mouse genes for vascular endothelial growth factor C. J Biol Chem 272: 25176-25183, 1997. (Pubitemid 27415703)
9. Timoshenko AV: Chitin hydrolysate stimulates VEGF-C synthesis by MDA-MB-231 breast cancer cells. Cell Biol Int, 2010.
10. Gabius HJ (ed.): The Sugar Code. Fundamentals of Glycosciences. Wiley-VCH, Weinheim, 2009.
11. Villalobo A, Nogales-Gonzalés A and Gabius HJ: A guide to signaling pathways connecting protein-glycan interaction with the emerging versatile effector functionality of mammalian lectins. Trends Glycosci Glycotechnol 18: 1-37, 2006.
12. André S, Sanchez-Ruderisch H, Nakagawa H, Buchholz M, Kopitz J, Forberich P, Kemmner W, Bock C, Deguchi K, Detjen KM, Wiedenmann B, von Knebel-Döberitz M, Gress TM, Nishimura SI, Rosewicz S and Gabius HJ: Tumor suppressor pl6INK4a: modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells. FEBS J 274: 3233-3256, 2007.
13. Patsos G, André S, Roeckel N, Gromes R, Geben J, Kopitz J and Gabius HJ: Compensation of loss of protein function in microsatellite-unstable colon cancer cells (HCT116): a genedependent effect on the cell surface glycan profile. Glycobiology 19: 726-734, 2009.
14. INK4a: downregulation of galectin-3, an endogenous competitor of the pro-anoikis effector galectin-I, in a pancreatic carcinoma model. FEBS J 277: 3552-3563, 2010.
15. Gabius HJ: Influence of type of linkage and spacer on the interaction of β-galactoside-binding proteins with immobilized affinity ligands. Anal Biochem 189: 91-94, 1990.
16. Sarter K, André S, Kaltner H, Lensch M, Schulze C, Urbonaviciute V, Schett G, Herrmann M and Gabius HJ: Detection and chromatographic removal of lipopolysaccharide in preparations of multifunctional galectins. Biochem Biophys Res Commun 379: 155-159, 2009.
17. Humphries MJ: Cell-substrate adhesion assays. In: Curr Protoc Cell Biol. Bonifacio JS et al. (eds.). John Wiley & Sons, New York, sections 9.1.1-9.1.11, 1998.
18. Lahm H, André S, Hoeflich A, Fischer JR, Sordat B, Kaltner H, Wolf E and Gabius HJ: Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures. J Cancer Res Clin Oncol 127: 375-386, 2001.
19. Satelli A, Rao PS, Gupta PK, Lockman PR, Srivenugopal KS and Rao US: Varied expression and localization of multiple galectins in different cancer cell lines. Oncol Rep 19: 587-594, 2008. (Pubitemid 351330422)
20. Imai K, Ichibangase T, Saitoh R and Hoshikawa Y: A proteomics study on human breast cancer cell lines by fluorogenic derivatization-liquid chromatography/tandem mass spectrometry. Biomed Chromatogr 22: 1304-1314, 2008.
21. Fischer C, Sanchez-Ruderisch H, Welzel M, Wiedenmann B, Sakai T, André S, Gabius HJ, Khachigian L, Detjen K and Rosewicz S: Galectin-1 interacts with the α5β1 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27. J Biol Chem 250: 37266-37277, 2005.
22. Moisa A, Fritz P, Eck A, Wehner HD, Mürdter T, Simon W and Gabius HJ: Growth/adhesion-regulatory tissue lectin galectin-3: stromal presence but not cytoplasmic/nuclear expression of tumor cells as negative prognostic factor in breast cancer. Anticancer Res 27: 2131-2140, 2007.
23. Saussez S, Decaestecker C, Cludts S, Ernoux P, Chevalier D, Smetana K, André S, Leroy X and Gabius HJ: Adhesion/growthregulatory tissue lectin galectin-1 in relation to angiogenesis/ lymphocyte infiltration and prognostic relevance of stromal upregulation in laryngeal carcinomas. Anticancer Res 29: 59-65, 2009.
24. Cludts S, Decaestecker C, Manillon V, Chevalier D, Kaltner H, André S, Remmelink M, Leroy X, Gabius HJ, Saussez S: Galectin-8 up-regulation during hypopharyngeal and laryngeal tumor progression and comparison with galectin-1, -3 and -7. Anticancer Res 29: 4933-4940, 2009.
25. Roda O, Ortiz-Zapater E, Martinez-Bosch N, Gutiérrez-Gallego R, Vila-Perelló M, Ampurdanés C, Gabius HJ, André S, Andreu D, Real FX and Navarro P: Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancreatic cancer. Gastroenterology 136: 1379-1390, 2009.